Saad Mark E sold Axsome Therapeutics ($AXSM) shares on the open market three times in the last year, totaling about $7.3 million, with the most recent sale on December 31, 2025. These sales rank 1,442nd among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. Saad Mark E made no open market purchases of $AXSM stock in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Common Stock | 6231 | $8.02 | 16,533.0000 | 50,412,640 | 60.48% | 0.01% |
| Dec. 31, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Stock Option (Right to Buy) | 31346 | $0.00 | 0.0000 | 50,412,640 | 100.00% | 0.06% |
| Dec. 31, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Stock Option (Right to Buy) | 6231 | $0.00 | 0.0000 | 50,412,640 | 100.00% | 0.01% |
| Dec. 31, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | S | Common Stock | 31346 | $165.18 | 10,302.0000 | 50,412,640 | 75.26% | 0.06% |
| Dec. 31, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Common Stock | 31346 | $4.95 | 41,648.0000 | 50,412,640 | 304.27% | 0.06% |
| Dec. 31, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | S | Common Stock | 6231 | $165.18 | 10,302.0000 | 50,412,640 | 37.69% | 0.01% |
| Sept. 5, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | S | Common Stock | 9127 | $125.07 | 10,302.0000 | 48,765,403 | 46.98% | 0.02% |
| Sept. 5, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Common Stock | 9127 | $9.00 | 19,429.0000 | 48,765,403 | 88.59% | 0.02% |
| Sept. 5, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Stock Option (Right to Buy) | 9127 | $0.00 | 0.0000 | 48,765,403 | 100.00% | 0.02% |
| June 6, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | A | Stock Option (Right to Buy) | 3166 | $0.00 | 3,166.0000 | 48,765,403 | 9999.99% | 0.01% |
| June 6, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | A | Restricted Stock Units | 1429 | $0.00 | 1,429.0000 | 48,765,403 | 9999.99% | 0.00% |
| Feb. 21, 2025 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | A | Stock Option (Right to Buy) | 1494 | $0.00 | 1,494.0000 | 48,765,403 | 9999.99% | 0.00% |
| Sept. 11, 2024 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | S | Common Stock | 11016 | $91.31 | 10,302.0000 | 0 | 51.67% | 0.00% |
| Sept. 11, 2024 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Stock Option (Right to Buy) | 11016 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 11, 2024 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | M | Common Stock | 11016 | $3.67 | 21,318.0000 | 0 | 106.93% | 0.00% |
| June 7, 2024 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | A | Stock Option (Right to Buy) | 5799 | $0.00 | 5,799.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Not found | A | Stock Option (Right to Buy) | 1519 | $0.00 | 1,519.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Director | A | Stock Option (Right to Buy) | 5681 | $0.00 | 5,681.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Saad Mark E | Director | A | Stock Option (Right to Buy) | 2224 | $0.00 | 2,224.0000 | 0 | 9999.99% | 0.00% |